USPTO serial 75878613
HEALTH QUOTIENT
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- SWAIN, MICHELE LYNN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with HEALTH QUOTIENT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
TIMOTHY D. PECSENYE
TIMOTHY D PECSENYE BLANK ROME COMISKY & MCCAULEY LLPONE LOGAN SQPHILADELPHIA, PA 19103-6998UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | HEALTH ASSESSMENTS | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 10, 2002 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Apr 15, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 15, 2002 | PAPER RECEIVED | — | |
| Nov 24, 2000 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Oct 23, 2000 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 19, 2000 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 1, 2000 | DOCK | ASSIGNED TO EXAMINER | — |
| May 26, 2000 | DOCK | ASSIGNED TO EXAMINER | — |